Cancer Biology and Therapy

Aims & Scope

Cancer Biology & Therapy aims to publish original research on the molecular basis of cancer, including articles with translational relevance to diagnosis or therapy.

We will include timely reviews covering the broad scope of the journal.

The journal will also publish op-ed pieces and meeting reports of interest.

The goal is to foster communication and rapid exchange of information through timely publication of important results using traditional as well as electronic formats.

The journal and the outstanding Editorial Board will strive to maintain the highest standards for excellence in all activities to generate a valuable resource.

Metrics & Ranking

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Directory of Open Access Journals (DOAJ)
• Web of Science
• Medline
• PubMed
• Embase

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Biochemistry, Genetics and Molecular Biology, Medicine and Pharmacology, Toxicology and Pharmaceutics, designed to support cutting-edge academic discovery.

Licensing & Copyright

This journal operates under an Open Access model. Articles are freely accessible to the public immediately upon publication. The content is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing users to share and adapt the work with proper attribution.

Copyright remains with the author(s), and no permission is required for non-commercial use, provided the original source is cited.

Policy Links

This section provides access to essential policy documents, guidelines, and resources related to the journal’s publication and submission processes.

• Aims scope
• Homepage
• Oa statement
• Author instructions
• License terms
• Review url
• Board url
• Copyright url
• Plagiarism url
• Preservation url
• Apc url
• License

Plagiarism Policy

This journal follows a plagiarism policy. All submitted manuscripts are screened using reliable plagiarism detection software to ensure originality and academic integrity. Authors are responsible for proper citation and acknowledgment of all sources, and any form of plagiarism, including self-plagiarism, will not be tolerated.

For more details, please refer to our official: Plagiarism Policy.

APC Details

The journal’s Article Processing Charge (APC) policies support open access publishing in Biochemistry, Genetics and Molecular Biology, Medicine and Pharmacology, Toxicology and Pharmaceutics, ensuring accessibility and quality in research dissemination.

This journal requires an Article Processing Charge (APC) to support open access publishing, covering peer review, editing, and distribution. The current APC is 4,595.00 AUD. Learn more.

Explore journals without APCs for alternative publishing options.

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Overview of cell death signaling pathways

  Citation: 877

  Authors: Zhaoyu, Wafik S.

• Current state of melanoma diagnosis and treatment

  Citation: 732

  Authors: Lauren E., Sara C., Alan J.

• Cancer cell killing via ROS: To increase or decrease, that is the question

  Citation: 659

  Authors: Jie, Jing

• Identification of fibroblast heterogeneity in the tumor microenvironment

  Citation: 587

  Authors: Hikaru, Thomas M, Mark W., Raghu

• The PIK3CA gene is mutated with high frequency in human breast cancers

  Citation: 514

  Authors: Kurtis E., Pedram, Yardena, Natalie, Janine, Steve, Hiroyuki, Bedri, Brian G., Clarence, Brock A., Victor E., Ben Ho

• Life and death of circulating cell-free DNA

  Citation: 467

  Authors: Anatoli, Ruth, Tamar, Albert

• Cycling to Cancer with Cyclin D1

  Citation: 375

  Authors: J. Alan

• Phase I dose escalation trial of docetaxel plus curcumin in patients with advanced and metastatic breast cancer

  Citation: 319

  Authors: Mathilde, Fabrice, Marianne, Françoise, Eloïse, Catherine, Marie-Ange, Xavier, Chantal, Philippe

• Rhebbing up mTOR: New Insights on TSC1 and TSC2, and the Pathogenesis of Tuberous Sclerosis

  Citation: 316

  Authors: David J.

• Histological, molecular and functional subtypes of breast cancers

  Citation: 288

  Authors: Gautam K., Xiangshan, Hamid, Vimla